1. Ren J, Jin X, Li J, Li R, Gao Y, Jingjing Zhang, et al. The global burden of peptic ulcer disease in 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Int J Epidemiol. 2022; 31(5): 1666-76. DOI: 10.1093/ije/dyac033 [
DOI:10.1093/ije/dyac033]
2. Sayehmiri K, Abangah Gh, Kalvandi Gh, Tavan H, Aazami S. Prevalence of peptic ulcer in Iran: Systematic review and meta‑analysis methods. J Res Med Sci. 2018; 23: 8. DOI: 10.4103/jrms.JRMS_1035_16. [
DOI:10.4103/jrms.JRMS_1035_16]
3. Tuerk E, Doss S, Polsley K. Peptic ulcer disease. Prim Care. 2023; 50(3): 351-62. DOI: 10.1016/j.pop.2023.03.003 [
DOI:10.1016/j.pop.2023.03.003]
4. McConaghy JR, Decker A, Nair S. Peptic Ulcer disease and H. pylori infection: common questions and answers. Am Fam Physician. 2023; 107(2): 165-72. PMID: 36791443
5. Narayanan M, Reddy KM. Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Mo. Med. 2018; 115(3): 219-24. PMID: 30228726
6. Victor E Reyes. Helicobacter pylori and Its Role in Gastric Cancer. Microorganisms. 2023; 11(5):1312. DOI: 10.3390/microorganisms11051312. [
DOI:10.3390/microorganisms11051312]
7. Silvia Salvatori ,Irene Marafini,Federica Laudisi ,Giovanni Monteleone, Carmine Stolfi. Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. Int. J. Mol. Sci. 2023, 24(3), 2895; DOI: 10.3390/ijms24032895 [
DOI:10.3390/ijms24032895]
8. Duan T, Yang, Xing Ch, Wang HY, Wang RF. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Front Immunol. 2022; 13: 812774. DOI: 10.3389/fimmu.2022.812774 [
DOI:10.3389/fimmu.2022.812774]
9. Pachathundikandi SK, Tegtmeyer N, Backert S. Masking of typical TLR4 and TLR5 ligands modulates inflammation and resolution by Helicobacter pyliri. Trends in microbiology. 2023; 31(9): 903-15. URL: 10.1016/j.tim.2023.03.009 [
DOI:10.1016/j.tim.2023.03.009]
10. Meliț LE, Mărginean CO, Mărginean CD, Mărginean MO. The Relationship between Toll-like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic. J Immunol Res. 2019; 2019(1): 8197048. DOI: 10.1155/2019/8197048. [
DOI:10.1155/2019/8197048]
11. Kim JH, Byeol Namgung, JeonYJ, SongWS, Lee J,Kang SG. Helicobacter pylori flagellin: TLR5 evasion and fusion-based conversion into a TLR5 agonist. Biochem Biophys Res Commun. 2018; 505(3):872-8. DOI: 10.1016/j.bbrc.2018.09.179. [
DOI:10.1016/j.bbrc.2018.09.179]
12. Tegtmeyer N, Neddermann M, Lind J, Pachathundikandi SK, Sharafutdinov I, Gutierrez-Escobar AJ, et al. Toll-like Receptor 5 Activation by the CagY Repeat Domains of Helicobacter pylori. Cell Rep. 2020; 32(11): 108159. DOI:
celrep.2020.108159 [
DOI:10.1016/j.]
13. Pachathundikandi SK, Tegtmeyer N, Arnold IC, Lind J, Neddermann M, Falkeis-Veit C, et al. T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat Commun. 2019; 10(1): 5717. URL: 10.1038/s41467-019-13506-6 [
DOI:10.1038/s41467-019-13506-6]
14. Kurz B, Arndt S, Unger P, Ivanova I, Berneburg M, Hellerbrand C, Karrer S. Association of polymorphous light eruption with NOD-2 and TLR-5 gene polymorphisms. J Eur Acad Dermatol Venereol. 2022; 36(11): 2172-80. DOI: 10.1111/jdv.18364 [
DOI:10.1111/jdv.18364]
15. Shuang C, Weiguang Y, Zhenkun F, Yike H, Jiankun Y, Jing X, et al. Toll-like receptor 5 gene polymorphism is associated with breast cancer susceptibility. Oncotarget. 2017; 8(51): 88622-9. DOI: 10.18632/oncotarget.20242 [
DOI:10.18632/oncotarget.20242]
16. Alsinnari YM, Alqarni MS, Attar M, Bukhari ZM, Almutairi M, Baabbad FM. Risk Factors for Recurrence of Peptic Ulcer Disease: A Retrospective Study in Tertiary Care Referral Center. Cureus. 2022; 14(2): e22001. DOI: 10.7759/cureus.22001 [
DOI:10.7759/cureus.22001]
17. Peiffer S, Pelton M, Keeney L, Kwon EG, Ofosu-Okromah R, Acharya Y, et al. Risk factors of perioperative mortality from complicated peptic ulcer disease in Africa: systematic review and meta-Analysis. BMJ Open Gastro. 2020; 7(1): e000350. DOI:10.1136/bmjgast-2019-000350 [
DOI:10.1136/bmjgast-2019-000350]
18. Malik JA, Kaur G, Agrewala JN. Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity. Int J Biol Macromol. 2023; 253(7): e127252. DOI: 10.1016/j.ijbiomac.2023.127252 [
DOI:10.1016/j.ijbiomac.2023.127252]
19. Yang J, Yan H. TLR5: beyond the recognition of flagellin. Cell Mol Immunol. 2017; 14(12): 1017-9. DOI:10.1038/cmi.2017.122 [
DOI:10.1038/cmi.2017.122]
20. Feng S, Zhang C, Chen S, He R, Chao G, Zhang S. TLR5 Signaling in the Regulation of Intestinal Mucosal Immunity. J Inflamm Res. 2023; 16: 2491-501. DOI: 10.2147/JIR.S407521 [
DOI:10.2147/JIR.S407521]
21. Jin S, Nepal N, Gao Y. The role of toll-like receptors in peptic ulcer disease Immunol Med. 2022; 45(2): 69-78. DOI: 10.1080/25785826.2021.1963190 [
DOI:10.1080/25785826.2021.1963190]
22. Noh J, Yoon S, Don Kim T, Inpyo Choi I,Jung H . Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy. J Immunol Res. 2020; 2020: 2045860. DOI: 10.1155/2020/2045860 [
DOI:10.1155/2020/2045860]
23. AL-Eitan L, Almomani FA, Al-Khatib SM, Aljamal HA, Al-Qusami MN, Aljamal RA. Association of toll-like receptor 4, 5 and 10 polymorphisms with Helicobacter pylori- positive peptic ulcer disease in a center in Jordan. Ann Saudi Med. 2021; 41(4): 206-15. DOI: 10.5144/0256-4947.2021.206. [
DOI:10.5144/0256-4947.2021.206]
24. Goda V, Jayaraman M, Loganathan R, Nazeer M, Ali M, Karunakaran P. TLR5 Polymorphisms rs2072493, rs5744174, and rs5744168 Are Not Genetic Risk Factors for Chronic Helicobacter pylori Infection in Indian Tamils. Immunol Invest. 2017; 46(6): 537-43. DOI: 10.1080/08820139.2017.1319381 [
DOI:10.1080/08820139.2017.1319381]
25. Xu T, Fu D, Ren Y, Dai Y, Lin J, Tang L. Genetic variations of TLR5 gene interacted with Helicobacter pylori infection among carcinogenesis of gastric cancer. Oncotarget. 2017; 8(19): 31016-22. DOI: 10.18632/oncotarget.16050 [
DOI:10.18632/oncotarget.16050]
26. Al Othaim A, Al-Hawary SI, Alsaab HO, Almalki SG, Najm MA, Hjazi A, et al. Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis. Front Genet. 2023; 14: 1280051. DOI: 10.3389/fgene.2023.1280051 [
DOI:10.3389/fgene.2023.1280051]
27. Meena NK, Ahuja V, Meena K, Paul J. Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis. PLOS One. 2015; 10(3): e0120697. DOI: 10.1371/journal.pone.0120697 [
DOI:10.1371/journal.pone.0120697]
28. Törmänen S, Teräsjärvi J, Lauhkonen E, Helminen M, Koponen P, Korppi M, et al. TLR5 rs5744174 gene polymorphism is associated with the virus etiology of infant bronchiolitis but not with post‐ bronchiolitis asthma. Health Sci Rep. 2018; 1(6): e38. DOI: 10.1002/hsr2.38 [
DOI:10.1002/hsr2.38]